Literature DB >> 10479127

The effect of drug-injection behavior on genetic evolution of HIV-1.

M Carneiro1, X F Yu, C Lyles, A Templeton, A E Weisstein, M Safaeian, H Farzadegan, D Vlahov, R B Markham.   

Abstract

The effect of injection-drug use on human immunodeficiency virus type 1 (HIV-1) env genetic evolution was examined in 15 seroconverting injection-drug users followed up for 4 years. After adjustment for non-drug-related independent variables significantly associated with genetic diversity (time since seroconversion and progressor status), injection frequency was positively and highly significantly associated with HIV-1 env genetic diversity (P=.003). The mutation rate in those who had injected at least once a day during the previous 6 months was estimated to be 62% greater than the rate in those who had not injected at all. If the positive effect of drug-injection frequency on env genetic diversity extends to the HIV-1 pol gene, the risk of emergence of resistance to antiretroviral drugs may be enhanced by increased drug-injection frequency, especially under the selection pressure of antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479127     DOI: 10.1086/315044

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Psychosocial factors and substance use in high-risk youth living with HIV: a multi-site study.

Authors:  Sylvie Naar-King; Karen Kolmodin; Jeffrey T Parsons; Debra Murphy
Journal:  AIDS Care       Date:  2010-04

Review 2.  HIV-1 transmission biology: selection and characteristics of infecting viruses.

Authors:  Manish Sagar
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

3.  Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes.

Authors:  Manish Sagar; Erin Kirkegaard; E Michelle Long; Connie Celum; Susan Buchbinder; Eric S Daar; Julie Overbaugh
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene.

Authors:  Jeanne Kowalski; Stephen J Gange; Michael F Schneider; Hua-Ling Tsai; Alan Templeton; Qiujia Shao; Guang Wen Zhang; Mei-Fen Yeh; Mary Young; Richard B Markham
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

5.  Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).

Authors:  Tomasz Laskus; Jeffrey Wilkinson; Roksana Karim; Wendy Mack; Marek Radkowski; Marina deGiacomo; Jonathan Nasseri; Zhi Chen; Jiaao Xu; Andrea Kovacs
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

6.  HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users.

Authors:  Valentine Budambula; Francis O Musumba; Mark K Webale; Titus M Kahiga; Francisca Ongecha-Owuor; James N Kiarie; George A Sowayi; Aabid A Ahmed; Collins Ouma; Tom Were
Journal:  AIDS Res Ther       Date:  2015-08-15       Impact factor: 2.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.